The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement.

MLA

Frohn, Michael, et al. “The Development of a Structurally Distinct Series of BACE1 Inhibitors via the (Z)-Fluoro-Olefin Amide Bioisosteric Replacement.” Bioorganic & Medicinal Chemistry Letters, vol. 30, no. 14, July 2020, p. 127240. EBSCOhost, https://doi.org/10.1016/j.bmcl.2020.127240.

APA

Frohn, M., Liu, L., Siegmund, A. C., Qian, W., Amegadzie, A., Chen, N., Tan, H., Hickman, D., Wood, S., Wen, P. H., Bartberger, M. D., Whittington, D. A., Allen, J. R., & Bourbeau, M. P. (2020). The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement. Bioorganic & Medicinal Chemistry Letters, 30(14), 127240. https://doi.org/10.1016/j.bmcl.2020.127240

Chicago

Frohn, Michael, Longbin Liu, Aaron C Siegmund, Wenyuan Qian, Albert Amegadzie, Ning Chen, Helming Tan, et al. 2020. “The Development of a Structurally Distinct Series of BACE1 Inhibitors via the (Z)-Fluoro-Olefin Amide Bioisosteric Replacement.” Bioorganic & Medicinal Chemistry Letters 30 (14): 127240. doi:10.1016/j.bmcl.2020.127240.